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Abstract
Background  and  objectives:  The  prophylactic  effect  of  ondansetron  on  subarachnoid  morphine-
induced  pruritus  is  controversial,  while  evidence  suggests  that  droperidol  prevents  pruritus.
The aim  of  this  study  is  to  compare  the  effects  of  droperidol  and  ondansetron  on  subarachnoid
morphine-induced  pruritus.
Methods:  180  ASA  I  or  II  patients  scheduled  to  undergo  cesarean  sections  under  subarachnoid
anesthesia combined  with  morphine  0.2  mg  were  randomized  to  receive,  after  the  child’s  birth,
metoclopramide  10  mg  (Group  I --  control),  droperidol  2.5  mg  (Group  II)  or  ondansetron  8  mg
(Group III).  Postoperatively,  the  patients  were  assessed  for  pruritus  (absent,  mild,  moderate  or
severe) or  other  side  effects  by  blinded  investigators.  Patients  were  also  blinded  to  their  group
allocation.  The  tendency  to  present  more  severe  forms  of  pruritus  was  compared  between
groups. NNT  was  also  determined.
Results:  Patients  assigned  to  receive  droperidol  [Proportional  odds  ratio:  0.45  (95%  conﬁ-
dence interval  0.23--0.88)]  reported  less  pruritus  than  those  who  received  metoclopramide.
Ondansetron  effect  was  similar  to  metoclopramide  [Proportional  odds  ratio:  0.95  (95%  conﬁ-
dence interval  0.49--1.83)].  The  NNT  for  droperidol  and  ondansetron  was  4.0  and  14.7,
respectively.
Conclusions:  Ondansetron  does  not  inhibit  subarachnoid  morphine-induced  pruritus.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved. Study performed at the Anesthesiology Department of the Universidade Católica de Pelotas, Pelotas, RS, Brazil.
∗ Corresponding author.
E-mail: marciolealhorta@gmail.com (F.F.C. Brião).
ttp://dx.doi.org/10.1016/j.bjane.2013.11.005
104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
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PALAVRAS-CHAVE
Droperidol;
Morﬁna;
Ondansetron;
Prurido;
Injec¸ão
subaracnoidea
Comparac¸ão  dos  efeitos  proﬁláticos  do  droperidol  e  do  ondansetron  sobre  o  prurido
provocado  pela  morﬁna  subaracnoidea
Resumo
Justiﬁcativa  e  objetivos:  O  efeito  proﬁlático  do  ondansetron  sobre  prurido  provocado  pela
morﬁna subaracnoidea  é  controverso,  enquanto  evidências  sugerem  que  o  droperidol  previne
o prurido.  O  objetivo  do  presente  trabalho  é  comparar  o  efeito  do  droperidol  com  o  do
ondansetron  sobre  o  prurido  provocado  pela  morﬁna  subaracnoidea.
Métodos:  180  pacientes  ASA  I ou  II  programadas  para  serem  submetidas  a  cesarianas  sob  aneste-
sia subaracnoidea  à  qual  foram  acrescentados  0,2  mg  de  morﬁna  foram  divididas  aleatoriamente
para receber,  logo  após  o  nascimento  da  crianc¸a,  10  mg  de  metoclopramida  (grupo  I  --  controle),
2,5 mg  de  droperidol  (grupo  II),ou  8  mg  de  ondansetron  (grupo  III).  No  período  pós-operatório  as
pacientes foram  avaliadas  quanto  ao  prurido  (ausente,  leve,  moderado  ou  intenso)  ou  outros
efeitos colaterais  por  observadores  que  não  sabiam  a  alocac¸ão  das  pacientes.  As  pacientes  tam-
bém não  sabiam  da  sua  alocac¸ão.  Os  grupos  foram  comparados  pela  sua  tendência  a  apresentar
formas mais  severas  de  prurido.  Também  determinamos  o  NNT.
Resultados:  As  pacientes  alocadas  para  receber  droperidol  [Odds  Ratio  Proporcional:  0,45
(Intervalo  de  Conﬁanc¸a  de  95%  0,23  --  0,88)]  relataram  menos  prurido  do  que  as  que  rece-
beram metoclopramida.  O  efeito  do  ondansetron  foi  semelhante  ao  da  metoclopramida  [Odds
Ratio Proporcional:  0,95  (Intervalo  de  Conﬁanc¸a de  95%  0,49  --  1,83)].  O  NNT  do  droperidol  foi
4,0 e  o  do  ondansetron  foi  14,7.
Conclusões:  O  ondansetron  não  inibiu  o  prurido  provocado  pela  morﬁna  subaracnoidea.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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iIntroduction
In  a  previous  work,1 we  compare  the  prophylactic  effect  of
droperidol,  alizapride,  propofol,  and  promethazine  on  sub-
arachnoid  morphine-induced  pruritus.  Droperidol  was  the
most  effective  agent;  propofol  and  alizapride  were  less
efﬁcient;  and  promethazine,  as  other  antihistamines,2 was
ineffective.  Kjelberg  and  Tramér,3 in  a  review  study  of
pharmacological  treatment  of  morphine-induced  pruritus,
concluded  that  droperidol  was  more  effective  than  any  other
drug,  other  than  morphine  antagonists.  But  their  review  only
included  one  study  in  which  ondansetron  was  used  to  antag-
onize  the  alfentanil-induced  pruritus  in  patients  undergoing
general  surgery.
Evidences  of  ondansetron  effectiveness  are  contradic-
tory.  Some  studies  have  reported  ondansetron  effectiveness
for  treating4 or  preventing  pruritus.5,6 It  has  also  been  sug-
gested  that  ondansetron  reduces  pruritus  severity  without
reducing  its  incidence.7 On  the  other  hand,  other  stud-
ies  have  reported  the  ineffectiveness  of  ondansetron  or  its
lower  efﬁcacy  compared  to  other  drugs.8--10
Given  this  contradiction  and  lack  of  comparison  between
droperidol  and  ondansetron,  we  decided  to  compare  the
prophylactic  effect  of  the  two  drugs  in  patients  undergoing
cesarean  section  (C-section).
MethodsThis  study  was  approved  by  the  Research  Ethics  Committee
of  the  Universidade  Católica  de  Pelotas  (Ref:  2011/18),  and
written  informed  consent  was  obtained  from  all  patients.
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ohis  randomized  double-blind  trial  enrolled  180  patients  ASA
 or  II  scheduled  for  C-section,  regardless  of  the  cause  of
bstetric  indication.  In  addition  to  the  refusal  to  participate
n  this  research,  patients  were  excluded  in  the  following
ases:  inadequate  anesthesia,  any  itchy  skin  disease,  recent
se  of  opioids  or  any  other  drug  that  causes  respiratory
epression,  hyperemesis,  or  inability  to  answer  questions
learly.
Upon  arrival  at  the  operating  room,  patients  received
n  infusion  of  Ringer’s  lactate  and  50  mcg  of  fentanyl  were
ntravenously  (IV)  administered.  The  total  volume  of  ﬂuid
nfused  during  surgery  was  recorded  in  three  moments:  at
umbar  puncture;  at  the  child’s  birth,  and  at  the  end  of
urgery.  Standard  monitoring  (non-invasive  blood  pressure,
pO2,  and  ECG)  was  established.
Subarachnoid  anesthesia  was  induced  via  the  lateral
pproach11 with  Quincke  needle  at  L2-L3  or  L3-L4,  using
 mL  of  5%  lidocaine  hyperbaric  solution  (100  mg)  or  4  mL
f  5%  bupivacaine  hyperbaric  solution  (20  mg).  Two  hundred
icrograms  of  morphine  was  added  to  the  injected  anes-
hetic.  The  manual  displacement  of  the  uterus  to  the  left
as  established  prophylactically  and,  in  case  of  hypoten-
ion  (systolic  blood  pressure  70%  of  baseline  values  or  below
0  mmHg),  improvement  in  displacement  was  attempted
nd/or  fractionated  doses  of  metaraminol  (0.5  mg  each)
ere  given.  As  the  leading  cause  of  hypotension  before
irth  is  cava  compression,  we  made  a  distinction  between
ts  incidence  before  birth  (initial  hypotension),  treated
ith  metaraminol  only  if  persisting  after  improving  the
anual  displacement,  and  hypotension  after  child  birth
ﬁnal  hypotension),  which  has  the  same  pathophysiology
f  hypotension  from  any  spinal  anesthesia  and  was  treated
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213 patients evaluated
Excluded (n=33)
Did not meet the inclusion criteria (28)
Refused to participate (5)
Randomized (n=180)
Allocated in metoclopramide
group (n=60)
 Allocated in droperidol
group (n=60)
 Allocated in ondansetron
group (n=60)
Evaluated (n=60) Evaluated (n=60) Evaluated (n=60)
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ith  fractionated  doses  of  metaraminol.  Shortly  after  birth,
5--20  units  of  oxytocin  were  used  to  obtain  good  uterine
ontraction.  In  three  cases,  0.2  mg  of  methylergometrine
ere  used  for  the  same  purpose.
The  distribution  of  180  participants  in  three  groups
f  60  patients  was  performed  using  a  table  of  random
umbers.  According  to  this  allocation  table,  immediately
fter  birth,  the  patients  in  Group  1  received  metoclo-
ramide  (10  mg);  patients  in  Group  II  received  droperidol
2.5  mg);  and  patients  in  Group  III  received  ondansetron
8  mg)  (Fig.  1).  In  Group  I,  metoclopramide  was  used  because
t  was  shown  that  it  has  no  effect  on  morphine-induced  pru-
itus,  so  it  can  be  used  to  prevent  nausea  and  vomiting
nd  as  a  placebo  for  morphine-induced  pruritus.  Induction
f  anesthesia  and  administration  of  drugs  in  the  operating
oom  were  performed  by  anesthesiologists  (FFCB  and  MLH).
n  the  postoperative  period,  patients  were  seen  by  anesthe-
iologists  unaware  to  their  experimental  allocation  (APB,  IS,
AN,  RB,  and  RA).  The  patients  were  also  blinded  to  the
reatment  received,  characterizing  the  double-blind  nature
f  this  study.  Patients  were  evaluated  every  six  hours  for  a
eriod  of  24  h.  After  this  period,  they  were  evaluated  twice
aily  until  discharge  from  hospital.  In  addition  to  pruritus,
ny  other  adverse  effects  seen  or  reported  by  the  patient,
ven  if  only  in  one  of  the  visits,  was  recorded  and  considered
ositive.
Pruritus  was  classiﬁed  as  absent;  mild  (restricted  to  one
rea,  such  as  face  or  arms,  and  not  disturbing  the  patient,
ometimes  denied  and  only  reported  after  insistence);
oderate  (affecting  a  larger  area,  such  as  face  and  arms  or
ace  and  anterior  surface  of  the  chest,  but  not  disturbing
he  patient  and  therefore  not  requiring  treatment)  or  inten-
ive  (extensive  or  generalized  pruritus,  often  disturbing
s
r
mrt  of  the  study.
he  patient  to  the  point  where  treatment  is  indicated).  It
as  registered  according  to  the  highest  intensity  seen  or
eported.  If  treatment  was  necessary,  droperidol  1.25  mg
as  used  intravenously.
Based  on  previous  studies,  we  estimate  that  the  inci-
ence  of  moderate  or  severe  pruritus  should  be  30%  in  the
ontrol  group,  and  that  an  effective  intervention  would
educe  the  incidence  by  60%.  The  sample  size  calculation
stimated  60  patients  per  group  for  a  signiﬁcance  level  of
5%  and  a power  of  80%.
For  data  analysis,  we  used  logistic  regression  to  estimate
he  trend  of  moderate  or  severe  pruritus  and  the  propor-
ional  trend  model  to  estimate  the  tendency  to  present  a
ore  severe  pruritus.  In  ordinal  regression,  the  proportional
odel  was  used  to  estimate  the  odds  ratio  and  the  presump-
ion  of  proportional  odds  was  assessed  using  Brant  test.  NNT
valuation  was  based  on  the  incidence  of  moderate  or  severe
ruritus.
esults
able  1  shows  that  the  distribution  of  some  basic  charac-
eristics  (age,  weight,  height,  BMI,  fasting  time,  number
f  previous  C-sections,  and  incidence  of  postoperative  nau-
ea  or  vomiting)  was  similar  between  groups.  There  was  no
ifference  between  groups  in  ﬂuid  replacement  volume  or
roportion  of  patients  who  received  treatment  for  hypoten-
ion.
Table  2  shows  that  the  proportion  of  subjects  who
eported  the  occurrence  of  pruritus  or  the  occurrence  of
ild  pruritus  was  higher  among  patients  in  droperidol  group.
Morphine-induced  pruritus  prophylactic  247
Table  1  Distribution  of  the  basic  characteristics  of  the  three  groups.
Metoclopramide  Droperidol  Ondansetron  p
Age  27.1  27.6  26.8  0.82
ASA I  patients  (%)  55.0  58.3  63.3  0.65
Weight 81.5  84.7  78.7  0.20
Height 162.1  163.1  162.0  0.78
Body mass  index  30.8  31.8  29.4  0.18
Fasting time  8.12  8.84  8.18  0.41
Previous cesarean 26.7  35.6  45.0  0.11
Nausea and  vomiting 3.3 5.0  6.6  0.7
Volume up  to  anesthesia 146.8 143.1 163.0 0.74
Volume  up  to  birth 245.7 254.6 308.7 0.23
Final  volume  504.2  538.8  369.1  0.67
Hypotension  (%)  40.0  35.0  48.3  0.16
Table  2  Incidence  and  severity  of  pruritus  in  the  three  groups.
Drugs  Pruritus
Absent  Mild  Moderate  Severe
Metoclopramide  9  (15%) 19  (31.7%)  25  (41.7%)  7  (11.7%)
Droperidol 14  (23.3%) 29  (48.3%) 12  (20%)  5  (8.3%)
3  (38
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Moreover,  the  incidence  of  severe  pruritus  was  lower  in
women  assigned  to  receive  droperidol.
Table  3  shows  that  the  tendency  to  present  with  a
stronger  form  of  pruritus  was  lower  among  patients  assigned
to  receive  droperidol.  The  tendency  to  present  with  a
stronger  form  of  pruritus  was  0.45  (95%  CI:  0.23--0.88)  for
patients  receiving  droperidol  compared  with  those  in  the
metoclopramide  group.  However,  ondansetron  group  was
similar  to  metoclopramide  group.  In  another  approach,  we
also  evaluated  the  tendency  to  present  with  moderate  or
severe  pruritus,  using  logistic  regression.  The  results  of  this
analysis  were  similar  to  those  observed  in  ordinal  regression,
with  patients  assigned  to  receive  droperidol  presenting  less
tendency  to  have  moderate  or  severe  pruritus  [odds  ratio
0.35  (95%  CI,  0.16--0.74)].
The  NNT  for  droperidol  was  4.0,  while  that  for
ondansetron  was  14.7.Discussion
Our  results  show  that  droperidol  was  more  effective
than  metoclopramide  and  ondansetron  both  when  we
u
v
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Table  3  Ordinal  and  logistic  regression  of  groups  2  and  3  (droperi
pramide) as  a  reference.
G
Ordinal  regression  --  odds  ratio  (95%  conﬁdence  interval)  R
Logistic regression  --  odds  ratio  of  persisting  moderate
to severe  pruritus  (95%  conﬁdence  interval)
R.3%) 17  (28.3%) 11  (18.3%)
pproached  the  trend  toward  moderate  or  severe  pruri-
us  or  when  the  severity  of  pruritus  was  the  approach
oint.
There  are  some  possible  explanations  for  the  differences
n  our  results  and  those  reported  in  the  literature.  First,  opi-
ids  are  different  in  their  pharmacokinetics,  and  morphine
as  a  very  long  action  when  administered  by  the  subarach-
oid  route.12 Therefore,  it  is  very  difﬁcult  to  compare
entanyl  or  sufentanil  with  morphine.  Another  difference  is
hat  the  incidence  of  pruritus  in  C-section  is  higher  than  in
ther  surgeries.5
Regarding  the  safety  of  the  use  of  droperidol,  there  are
eports  of  arrhythmias,13 but  it  was  not  seen  in  our  previ-
us  investigation,  when  we  use  1.25  mg  of  droperidol  in  60
atients,  neither  in  this  study  with  the  dose  of  2.5  mg.  In  any
ase,  it  seems  interesting  to  use  lower  doses  of  droperidol
n  order  to  study  its  effectiveness.
In  summary,  our  study  shows  that  ondansetron  does  not
nhibit  subarachnoid  morphine-induced  pruritus  in  patients
ndergoing  C-section.  These  results,  combined  with  our  pre-
ious  results,  allow  us  to  say  that  droperidol  is  a satisfactory
rug  to  antagonize  the  subarachnoid  morphine-induced  pru-
itus.
dol  and  ondansetron,  respectively),  having  group  1  (metoclo-
roup  1  Group  2  Group  3
eference  0.45  (0.24--0.88)  0.95  (0.49--1.83)
eference  0.35  (0.16--0.74)  0.77  (0.37--1.57)
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